NEA Management Company as of March 31, 2015
Portfolio Holdings for NEA Management Company
NEA Management Company holds 36 positions in its portfolio as reported in the March 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Tesaro | 25.6 | $566M | 9.9M | 57.40 | |
Groupon | 14.4 | $319M | 44M | 7.21 | |
Clovis Oncology | 7.7 | $169M | 2.3M | 74.23 | |
Supernus Pharmaceuticals (SUPN) | 5.8 | $129M | 11M | 12.09 | |
Hyperion Therapeutics | 5.0 | $109M | 2.4M | 45.90 | |
Epizyme | 4.4 | $97M | 5.1M | 18.78 | |
Opower | 4.1 | $91M | 9.0M | 10.13 | |
Cvent | 3.8 | $84M | 3.0M | 28.04 | |
Ardelyx (ARDX) | 3.3 | $74M | 5.6M | 13.09 | |
Glycomimetics (GLYC) | 3.2 | $71M | 8.6M | 8.32 | |
Nevro (NVRO) | 3.0 | $66M | 1.4M | 47.93 | |
Dermira | 2.4 | $54M | 3.5M | 15.35 | |
Trivascular Technologies | 1.9 | $41M | 3.9M | 10.49 | |
Trevena | 1.4 | $31M | 4.8M | 6.52 | |
Vitae Pharmaceuticals | 1.4 | $31M | 2.6M | 11.71 | |
Orexigen Therapeutics | 1.3 | $29M | 3.7M | 7.83 | |
Tracon Pharmaceuticals | 1.2 | $27M | 1.9M | 14.04 | |
Care | 1.1 | $25M | 3.3M | 7.58 | |
Loxo Oncology | 1.0 | $22M | 1.8M | 12.45 | |
Zosano Pharma | 1.0 | $22M | 2.2M | 10.11 | |
Aerohive Networks | 1.0 | $22M | 4.9M | 4.46 | |
Boingo Wireless | 0.8 | $19M | 2.5M | 7.54 | |
Lexicon Pharmaceuticals | 0.7 | $16M | 17M | 0.94 | |
Targacept | 0.6 | $14M | 4.6M | 2.97 | |
Millennial Media | 0.5 | $12M | 8.2M | 1.45 | |
Rigel Pharmaceuticals | 0.5 | $12M | 3.2M | 3.57 | |
Sunesis Pharmaceuticals | 0.5 | $11M | 4.7M | 2.45 | |
Aurinia Pharmaceuticals (AUPH) | 0.5 | $11M | 2.5M | 4.36 | |
Roka Bioscience | 0.5 | $10M | 3.2M | 3.20 | |
Zhone Technologies | 0.3 | $6.2M | 4.8M | 1.30 | |
ArQule | 0.3 | $5.6M | 2.5M | 2.24 | |
Exelixis (EXEL) | 0.3 | $5.7M | 2.2M | 2.57 | |
Paratek Pharmaceuticals | 0.2 | $5.4M | 174k | 31.26 | |
Channeladvisor | 0.2 | $5.4M | 557k | 9.69 | |
Agile Therapeutics | 0.1 | $1.2M | 134k | 9.27 | |
NeuroMetrix | 0.0 | $96k | 57k | 1.68 |